ClinicalTrials.Veeva

Menu

Post-op Prednisone and Glucose Monitoring in TKA

Columbia University logo

Columbia University

Status and phase

Enrolling
Phase 4

Conditions

Unicompartmental Knee Arthroplasty
Osteoarthritis
Total Hip Arthroplasty (THA)

Treatments

Other: InkWell Health Tattoos
Device: Continuous Glucose Monitor
Drug: Prednisone

Study type

Interventional

Funder types

Other

Identifiers

NCT07630896
AAAV7556

Details and patient eligibility

About

This study compares the efficacy of a 5-day post-operative oral prednisone regimen (40 mg daily) with the standard intraoperative steroid regimen, focusing on pain, swelling, range of motion, opioid use, and glucose levels monitored continuously.

Enrollment

104 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • MUST BE CONTACTED BY THE STUDY TEAM TO BE PART OF THE STUDY. No applications taken
  • Undergoing Primary Unicompartmental Knee Arthroplasty or Total Hip Arthroplasty
  • Age 18 and above
  • Patient at Columbia University Irving Medical Center and be undergoing planned surgery by Dr. Roshan P. Shah

Exclusion criteria

  • Steroid therapy
  • Narcotic use within past 3 months
  • History of corticosteroid intolerance
  • Pregnancy
  • Uncontrolled diabetes
  • Doesn't own smart phone

Drop Criteria:

- 2nd dose of IV dexamethasone

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

104 participants in 2 patient groups, including a placebo group

Post-operative Steroids
Active Comparator group
Description:
Participants will receive a 5-day regimen of 40 mg oral prednisone postoperatively.
Treatment:
Drug: Prednisone
Device: Continuous Glucose Monitor
Other: InkWell Health Tattoos
Standard of care
Placebo Comparator group
Description:
Participants will receive standard of care treatment, consisting of the intravenous administration of dexamethasone and periarticular administration of steroids intraoperatively.
Treatment:
Device: Continuous Glucose Monitor
Other: InkWell Health Tattoos

Trial contacts and locations

1

Loading...

Central trial contact

Jacqueline Lenahan

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems